Her2-low/ HRR proficient early triple negative breast cancer is characterized by good prognosis

被引：0
|
作者：
Pellegrino, B. [1 ]
Tornali, C. [2 ]
Lazzarin, A. [3 ]
Cotelli, B. [2 ]
Ingallinella, A. [2 ]
Campanini, N. [4 ]
Tommasi, C. [5 ]
Coriano, M. [6 ]
Serra, O. [7 ]
Michiara, M. [8 ]
Boggiani, D. [9 ]
Schirone, A. [10 ]
Casarini, C. [11 ]
Cretella, E. [12 ]
Zoppoli, G. [13 ,14 ]
Lambertini, M. [15 ]
Botosso, M. [16 ]
Cortesi, L. [17 ]
Silini, E. M. [18 ]
Musolino, A. [19 ]
机构：
[1] Osped Maggiore Parma, Oncol Dept, Parma, Italy
[2] Univ Parma, Oncol, Parma, Italy
[3] Univ Parma, Med Oncol Dept, Parma, Italy
[4] Univ Parma, Fac Med & Chirurg, Pathol, Parma, Italy
[5] Univ Parma, Fac Med & Chirurg, Med Oncol & Breast Unit, Parma, Italy
[6] Azienda Osped Univ Parma, Oncol, Parma, Italy
[7] Univ Parma, Fac Med & Chirurg, Oncol, Parma, Italy
[8] Osped Maggiore Parma, Oncol, Parma, Italy
[9] Univ Hosp Parma, Oncol, Parma, Italy
[10] Arcispedale SantAnna AOU Ferrara, Med, Ferrara, Italy
[11] Nuovo Osped Sassuolo, Oncol, Sassuolo, Italy
[12] Osped Cent Bolzano ASDAA SABES, Oncol Dept, Bolzano, Italy
[13] Univ Genoa, Dept Internal Med, Genoa, GE, Italy
[14] Osped Policlin San Martino IRCCS, DiMI, Genoa, GE, Italy
[15] IRCCS AOU San Martino, IST Ist Nazl Ric Canc, Oncol, Genoa, Italy
[16] IOV Ist Oncol Veneto IRCCS, Oncol, Padua, Italy
[17] Azienda Osped Univ Policlin Modena, Haematol & Oncol Dept, Modena, Italy
[18] Univ Parma, Pathol, Parma, Italy
[19] Univ Parma, Fac Med & Chirurg, Dept Med, Parma, Italy
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.212
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
269P
引用
收藏
页码：S328 / S329
页数：2
相关论文
共 50 条
  • [31] Prognostic and biologic significance of HER2-low expression in early breast cancer
    Tarantino, P.
    Jin, Q.
    Tayob, N.
    Jeselsohn, R.
    Schnitt, S. J.
    Vincuilla, J.
    Parker, T.
    Tyekucheva, S.
    Lin, N. U.
    Hughes, M.
    Weiss, A. C.
    King, T. A.
    Mittendorf, E. A.
    Curigliano, G.
    Tolaney, S. M.
    ANNALS OF ONCOLOGY, 2022, 33 : S124 - S124
  • [32] UPDATE ON TRIPLE-NEGATIVE BREAST CANCER: THE GOOD PROGNOSIS
    Sakhri, S.
    Hamza, K.
    Kamoun, S.
    Houcine, Y.
    Karima, T.
    Bouhani, M.
    Bettaib, I.
    Driss, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A306 - A306
  • [33] HER2-Low Breast Cancer: a New Subtype?
    Corti, Chiara
    Giugliano, Federica
    Nicolo, Eleonora
    Tarantino, Paolo
    Criscitiello, Carmen
    Curigliano, Giuseppe
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (05) : 468 - 478
  • [34] HER2-Low Breast Cancer: Now and in the Future
    Kang, Sora
    Kim, Sung-Bae
    CANCER RESEARCH AND TREATMENT, 2024, 56 (03): : 700 - 720
  • [35] HER2-Low Breast Cancer: a New Subtype?
    Chiara Corti
    Federica Giugliano
    Eleonora Nicolò
    Paolo Tarantino
    Carmen Criscitiello
    Giuseppe Curigliano
    Current Treatment Options in Oncology, 2023, 24 : 468 - 478
  • [36] Clinical Significance of HER2-low Breast Cancer
    Zaiem, Fadi
    AbuJamea, Asem
    Kheil, Mira
    Numi, Anna
    Abbas, Omar
    Awada, Sanaa
    Almsaddi, Ragad
    Al-Juburi, Saleh
    Larson, Lauren
    Jain, Deepti
    AlSaghir, Maya
    Jang, Hyejeong
    Kim, Seongho
    Bandyopadhyay, Sudeshna
    Jaiman, Sunil
    Ali-Fehmi, Rouba
    CANCER RESEARCH, 2024, 84 (09)
  • [37] Is HER2-low a biologically distinct breast cancer (BC) subtype? Prognosis and pathological complete response rate after neoadjuvant treatment (NAT) in early breast cancer (BC) HER2 negative
    Gil-Torralvo, Ana
    Rodriguez, Yeray
    Falcon, Alejandro
    Morales, David
    Cejuela, Monica
    Miras, Isabel
    Amerigo, Marta
    Ruiz-Borrego, Manuel
    Bayo, Juan
    Bofill, Francisco Javier Salvador
    CANCER RESEARCH, 2024, 84 (09)
  • [38] Biology and Treatment of HER2-Low Breast Cancer
    Nicolo, Eleonora
    Tarantino, Paolo
    Curigliano, Giuseppe
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (01) : 117 - 132
  • [39] A rapid, non-invasive test to determine HER2-low status in triple negative breast cancer (TNBC) patients
    Cook, Daniel
    Patel, Snehal
    Whitman, John
    Hobbs, Nicole
    Lopez-Ramos, Dorys A.
    Pfeiffer, John
    Peterson, Joseph
    Pandey, Tushar
    Antony, Anuja K.
    Cole, John
    CANCER RESEARCH, 2023, 83 (07)
  • [40] Epidemiology of HER2-low breast cancer in Lithuania
    Cesas, A.
    Poskiene, L.
    Valkiuniene, R. B.
    Radvinskiene, L.
    Lege, I.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 103 - 104
12345